Assignment of Assignor's Interest

Recorded: 2026-06-22 Pages: 3

Assignors

GETTS, DANIEL

Executed: 2022-11-17

WANG, YUXIAO

Executed: 2022-11-17

MCCREEDY, BRUCE, JR.

Executed: 2022-11-28

Assignee

MYELOID THERAPEUTICS, INC.

300 TECHNOLOGY SQUARE, SUITE 203, CAMBRIDGE, MASSACHUSETTS, 02139

Covered Property (1)

Engineered Chimeric Fusion Protein Compositions and Methods of Use Thereof

Application: 18/434,220 →

Publication: US 2024/0252630

Related Assignments (2)

Other recorded transfers of the patent in this record — the chain of ownership.